Search results
Latest Trial Over Zantac Cancer Claims Called Off as Plaintiff Drops Case
Insurance Journal· 1 day agoA woman who claimed in a lawsuit that GSK’s discontinued heartburn drug Zantac caused her breast...
Bull Market and Beyond: 3 Stocks Just Waiting to Soar | The Motley Fool
The Motley Fool· 1 day agoThe S&P 500 rose to a record high earlier this year, confirming its presence in a bull market, and...
Société BIC And 2 Other Prominent Dividend Stocks On Euronext Paris
Simply Wall St. via Yahoo Finance· 1 day agoAmidst a backdrop of cautious optimism in European markets, where recent ECB rate cuts have stirred...
Novavax, With A 369% Gain, Reverses Bullish Gains After Key FDA Move
Investor's Business Daily· 6 days agoRecent news, though, has set Novavax stock on a sprint. Shares skyrocketed more than 125% on May 10...
New Covid Boosters Get a Thumbs-Up From FDA. Vaccine Stocks Are Wavering.
Barrons.com· 6 days agoDrugmakers are aiming to launch this year’s shots by the beginning of September but have been...
FDA Panel Backs Eli Lilly's Biogen-Rivaling Alzheimer's Drug
Investor's Business Daily· 2 days agoAll 11 members of the FDA's Peripheral and Central Nervous System Drugs Advisory Committee voted...
FDA OKs Sarilumab for Polyarticular JIA
Medscape· 1 day agoThe approval applies to patients weighing ≥ 63 kg, the announcement said.
Questor: Investors are undervaluing this London company’s pubs and hotels
The Telegraph via Yahoo Finance· 2 days agoWe are hopefully not tempting providence by taking a fresh look at Fuller Smith & Turner ahead of...
Geron wins long-sought drug approval; Califf talks China, GLP-1s at BIO
BioPharma Dive via Yahoo Finance· 5 days agoAfter 34 years, Geron finally has an approved medicine in Rytelo. Elsewhere, Shionogi disclosed...
Candy maker Mars is the biggest vet provider in the country: Inside its sprawling operation
Fortune via Yahoo Finance· 2 days agoThe VCA acquisition remains the second biggest sale in the pet clinic space, behind Boehringer...